HemaTerra Technologies Received Investment from The Riverside Company
The platform investment will enable HemaTerra to scale and bring significant value to the complex ecosystem of blood donors, volunteers, collection centers, hospitals, and pharmaceutical companies.
HemaTerra Technologies is a provider of cloud-based solutions for independent and hospital-based blood and plasma collection centers that connects a complex supply chain of donors, volunteers, collection centers, hospitals, and pharmaceutical companies.
The Company offers an unrivaled solution for the full lifecycle of blood centers, including donor recruitment, online order entry, inventory management, equipment management, quality control tracking, staff scheduling, and blood drive scheduling.
The Riverside Company is a global private equity firm focused on making control and non-control investments in growing businesses.
New York City, NY & Cleveland, OH
Discover more SEG Success Stories
PRESS RELEASE OVERVIEW
SEG Client, HemaTerra Technologies, Received Investment from The Riverside Company
Software Equity Group (SEG) announces its client, HemaTerra Technologies, has received an investment from The Riverside Company. HemaTerra is a provider of cloud-based solutions for independent and hospital-based blood and plasma collection centers that connects a complex supply chain of donors, volunteers, collection centers, hospitals, and pharmaceutical companies. SEG served as the exclusive advisor to HemaTerra.
The company’s family of software products helps customers with donor recruitment and management, online order entry, inventory management, equipment management, quality control tracking, staff scheduling and blood drive scheduling. HemaTerra’s software is used to manage a complex ecosystem of constituents that involves donors, volunteers, collection centers, hospitals and pharmaceutical companies.
“We are thrilled to work with HemaTerra’s management team to build on its already excellent product suite,” said Riverside Managing Partner Loren Schlachet. “The blood and plasma industry is a complex ecosystem involving numerous parties. We plan to help HemaTerra invest in additional product functionality that improves the donor experience and assists collection centers with managing their supply chain.”
HemaTerra is another example of Riverside’s commitment to investing in software and healthcare companies. To date, the firm has completed more than 150 investments in these areas and has a team of global experts dedicated to growing companies in these specializations.
“We chose to partner with Riverside because they share our view of the importance of providing top-notch software products and service to the blood, plasma and hospital industry,” said HemaTerra CEO Todd Collins. “Together, we will be able to enhance our leadership position and continue exceeding what our customers have come to expect from us.”
Riverside intends to build on HemaTerra’s outstanding product offerings by investing in new product development, enhancing sales and marketing and pursuing strategic partnerships and combinations.
“In addition to having an unbeatable reputation in the industry, HemaTerra is the niche leader in offering such a robust suite of solutions,” said Riverside Partner Joe Manning. “It’s no surprise they count many of the most sophisticated and well-known blood centers, plasma centers and hospitals as customers. We look forward to providing HemaTerra the financial and strategic resources they need to support continued growth.”